1 report

Its lead product candidate Syndros (dronabinol oral solution) is intended for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS.

  • Opioid
  • Pharmaceutical
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.